Softbox continues to make its mark globally see more
COVAX momentum continues – but there is still much to be done.
Last month, COVAX reached an extraordinary milestone with the delivery of more than 1.5 billion doses of the COVID-19 vaccine to 145 countries and territories.
Since the start of the pandemic, we have been enabling delivery of COVID-19 vaccines to people around the world, with temperature controlled shipping solutions that keep vaccinations safe and efficacious from point of manufacture to people’s arms.
And just recently, on June 18, the US sent 302,400 pediatric doses of Pfizer COVID-19 vaccine to Mongolia – a COVAX delivery with support from USAID.
Earlier in the month, COVAX also supported the delivery of 58,500 COVID-19 vaccine doses in Mali. Thanks to MSDS, the US Embassy in Mali, COVAX, UNICEF and other partners – as well as a secure cold chain – safe and effective vaccines continue to reach populations across the globe.
COVAX vaccines being transported in Softbox by CSafe parcel shippers in June 2022.
These recent consignments are just latest in a steady stream of donations through COVAX facilities. Just before this, the US donated 23,400 COVID-19 vaccine doses that arrived safely Kiribati.
COVID-19 vaccines arriving in Kiribati. Photo © UNICEFPacific/2022/Temakei
Throughout Spring we saw further COVAX donations reach destinations around the world – from Armenia to Zambia and countless others. Pictured below are our Silverpod pallet shippers containing COVID-19 vaccines as part of the UNICEF, GAVI, CEPI, WHO COVID-19 vaccine consignment in Armenia in March.
And in April, the US Department of State announced that US had donated 529 million COVID-19 vaccine doses to over 110 countries and economies – we were proud to see our temperature control systems in the coverage of this World Immunization Week milestone, too.
These incredible efforts are testament to the hard work and collaboration shown by so many, and these deliveries will protect public health and economies. But lack of vaccine equity remains – and there is still much work to be done.
The cold chain is part of this continued focus. As we know, COVID-19 vaccines are temperature-sensitive, and can be spoiled or lose efficacy if this chain is broken – so our work continues in earnest too.
Rebuttal to a factually inaccurate and decidedly slanted article about a member of SC life sciences see more
South Carolina is blessed with over 1,000 life sciences organizations, engaged in biotechnology and pharmaceuticals to medical devices and health IT. Never was this more important than during the pandemic, when millions were hospitalized and too many lives lost.
As neighbors fell ill, our industry -- including Charles River Laboratories professionals -- stepped up. Over 100 organizations produced PPE, tested for COVID-19, conducted vaccine clinical trials, and expedited health solutions. Gov. McMaster expressed appreciation by declaring Life Sciences Week in South Carolina.
As our state’s voice of life sciences, SCBIO wishes your “Monkeys & Blood” article had highlighted Charles River’s globally celebrated work that helps save millions of lives and improves patient safety.
Carefully obtained from Atlantic horseshoe crabs by Charles River professionals, Limulus amebocyte lysate (LAL) is critical to saving lives of patients everywhere. The unique, natural substance is used to test every injectable pharmaceutical, implantable medical device, and approved COVID-19 vaccine against contamination. Without it, endotoxins could enter the body and produce life-threatening sepsis.
For decades, Charles River has protected and nurtured our crab population. Its microbial testing is considered best-in-class by scientists globally. And with synthetic LAL neither readily available nor FDA-licensed, industry experts decline its sole use because the safety of IVs, vaccines and more would not be assured as with natural LAL.
Charles River and our life sciences ecosystem make tremendous contributions to our state and the health of mankind. Their lifesaving medical innovations should be celebrated.
James Chappell, CEO of SCBIO
VCOM receives DHEC’s COVID-19 Community Hero Award see more
The Edward Via College of Osteopathic Medicine was recognized by the state Department of Health and Environmental Control for its efforts to provide vaccines to medically underserved communities across the Upstate.
VCOM received DHEC’s COVID-19 Community Hero Award on Jan. 10 for administering vaccines through their COVID vaccination clinic and mobile medical unit. The mobile medical unit is an RV that has been converted into a medical facility.
“We are both humbled and honored to receive this award,” said Matthew Cannon, dean of VCOM’s Carolinas campus in Spartanburg. “This was certainly not something that was expected, but it was truly a testimony to our school’s mission.”
In the spring of 2020, VCOM partnered with DHEC to hold school-based mobile vaccine clinics for rising sixth and seventh graders to ensure that they had all required vaccines to start school. The effort led to 18 mobile clinics and was a part of a pilot mobile vaccination program for the Cherokee County School District. Mobile COVID-19 vaccines were held at six locations across the Upstate, including at Tri-County Technical College and Dorman High School.
Throughout the pandemic, VCOM was able to administer routine vaccines for children — such as MMR, tetanus, diphtheria, polio and varicella — who were unable to visit a doctor. The medical school partnered with DHEC in 2021 to open a clinic in the Northside area of Spartanburg, which serves as a COVID-19 vaccine administration site across the street from VCOM.
“This has been a pleasure because this has really been truly a joint effort,” said Kandi Fredere, Upstate regional public health director for DHEC. “And everybody’s been at the table really talking through, problem solving and thinking what works best for everybody involved.”
When it came to vaccine distribution, Softbox saved the day. see more
When a pneumonia and meningitis immunization program needed to be rolled out worldwide, the safe transportation of vaccines was a crucial component in the process.
The global bio-pharmaceutical company leading this initiative required a totally reliable, cost-effective Temperature Control Packaging solution to support its drive – and one that was ideal for air transportation.
The award-winning Softbox Silverpod® range was tailor-made for just this kind of activity. Not only was the entire global distribution program completed, but it was done so without any product excursions whatsoever.
Pall expects to hire even more associates in 2022 see more
Pall Corporation announced Nov. 8 it will hire 300 people to staff its new 220,000-square-foot manufacturing facility at 816 Berry Shoals Road in Duncan.
The facility manufactures products such as its Allegro platform, which may be used in the creation, purification and packaging processes for biotechnology and pharmaceutical products such as antibiotics, antibodies and vaccines, including COVID-19 vaccines.
“We’re excited to join the Duncan community and welcome new associates to our growing team,” said Joseph Repp, president, Pall Life Sciences. “Pall has a proud, 75-year history of supporting development of life-saving vaccines and therapeutics. The important products we make here in South Carolina are used by customers around the world and critical to Pall’s global expansion plans as we increase production globally.”
The company also expects to hire for additional positions in 2022.
To apply for open positions, visit jobs.danaher.com/global/en and search for ‘South Carolina’ as the role location.
Nephron steps up to help state's most vulnerable see more
As children ages 5 to 11 become eligible for COVID-19 vaccines, Nephron Pharmaceuticals Corporation has announced the opening of a pediatric COVID-19 vaccine clinic at its vaccination drive-thru in West Columbia. The clinic is open Monday – Friday from 12:00 PM – 5:30 PM.
Nephron, in partnership with Dominion Energy South Carolina, launched a convenient drive-thru COVID-19 vaccination site earlier this year. The drive-thru is located on Dominion Energy property off of I-77 at Exit 2. In addition to providing the space for a drive-thru, Dominion Energy is also generously contributing power and logistics support.
As a part of its ongoing efforts to help respond to the COVID-19 pandemic, Nephron offers Pfizer and Moderna vaccinations to citizens, including those ages 5 to 11, who are eligible. This includes regular doses and boosters for adults, during regular hours, which remain Monday – Friday from 10:00 AM – 4:00 PM.
Nephron registered nurses and pharmacists are administering vaccinations, with assistance from Nephron CLIA-certified diagnostics lab employees.
COVID-19 tests are also available as a part of the drive-thru. Nephron established a diagnostics lab last year in order to conduct COVID-19 tests. Since opening the lab, Nephron has tested thousands of people across the state for COVID-19 – including employees, students, educators, athletes and families – as the company does its part to keep South Carolina healthy and safe during the public health crisis. The Nephron CLIA-certified lab procured state-of-the-art technology for COVID-19 real-time PCR testing and serological antibody testing. Results are delivered within 24-48 hours.
South Carolina and National executive address what's next for South Carolina as we battle COVID. see more
On September 9, 2021 SCBIO hosted a statewide webinar program entitled "COVID-19 and South Carolina: What's Next?". The program was attended by a large audience across South Carolina, including business leaders, healthcare executives, elected officials, and regional media.
BIO’s Phyllis Arthur, Nephron Pharmaceutical’s Lou Kennedy and VCOM’s Matt Cannon shared their views on what obstacles we have to overcome to get through this latest surge, using science as the foundation. This discussion also addressed the science, data and real life experiences confronting us all as we manage our response to the Delta Variant of COVID-19. It’s a conversation you won’t want to miss if you aren’t sure about vaccines, antibodies, masks and more.
Top executives opine on what's next for SC as Covid surges see more
After attending a Chamber of Commerce breakfast where a hospital CEO ticked off statistics about the number of unvaccinated patients suffering from Covid – many in their 20s and 30s – Nephron Pharmaceuticals CEO Lou Kennedy decided something had to be done.
So she mandated vaccination at her company and today, everyone at the West Columbia business, which manufactures generic respiratory products, has had the shot, she said. And she lost just 30 out of 2,000 employees over the decision.
“It was the right thing to do, and I encourage my fellow business leaders to follow suit,” Kennedy said. “Somebody had to be the first to do it, and why not make it us.”
In addition, Kennedy said, the company spent $2.5 million last year on people being out of work and overtime to cover them – money that could have been spent on innovation, such as the mask the company introduced for patients getting nebulizer treatments that protects the health care provider from respiratory droplets.
Kennedy spoke at an online event hosted by SC BIO, the Palmetto State’s life sciences group, to discuss what comes next in the pandemic.
South Carolina is still lagging in vaccinations, said SC BIO interim CEO Erin Ford, with Covid deaths on the rise.
By Sept. 7, just 49 percent of residents had been fully vaccinated, and 58 percent had had at least one shot, according to the state Department of Health and Environmental Control.
Meanwhile, nearly 780,000 cases had been confirmed by that date and 11,050 South Carolinians had died, DHEC reports.
But the number of vaccinations is slowly rising, Ford said, offering some hope that things will turn around.
The full FDA approval of the Pfizer vaccine pushed some people to get vaccinated in recent weeks, said Phyllis Arthur, vice president of infectious diseases and diagnostic policy at BIO Global, the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions.
But many are rolling up their sleeves after seeing how the Delta variant left loved ones sick and dying, she said.
“Delta is nearly twice as contagious as the previous variants,” she said. “And … (it) moved so quickly and spread so fast we saw a giant spike in cases and deaths. When immunization numbers go up, we will see cases come down.”
The speakers agreed that the greatest obstacle to making progress in the fight against the virus is the politicization of the pandemic and misinformation.
“There’s no R or D in the word science. It has nothing to do with your favorite politician,” said Kennedy. “This is science.”
Arthur said people should beware of misinformation and trust the scientists who’ve done the work on the virus.
“One of the things I ask people to do is look at the source of what you’re reading and hearing,” she said. “Look at the data yourself. It’s all publicly available and it’s very transparent.
And Dr. Matthew Cannon, dean of the Carolinas Campus of the Edward Via College of Osteopathic Medicine, agreed.
“(It’s) being politicized, in my opinion, and I just hope people would look at it objectively, not through partisanship,” he said. “This is a public health crisis.”
Cannon said that as of Sept. 7, one Upstate hospital had 278 Covid patients and all but 25 were unvaccinated. Another had 566 Covid patients and all but 41 were unvaccinated. The average age of the vaccinated patients was 75 to 78, he said, and they were immunocompromised. The average age of the unvaccinated patients was 50, he said.
Though breakthrough cases occasionally occur among the vaccinated, Arthur said they typically are milder and of shorter duration.
She said she expects FDA approval of the Pfizer vaccine for children younger than 12 in the next month or so and the Moderna vaccine in the next few months.
Kennedy said her antibody level dropped from 6,900 to 3,800 in recent weeks and is watching to see when the booster is approved.
There are still two steps to go before a booster is approved for the general population, but that it could come in a matter of weeks, Arthur said.
And Cannon said the college is working on research to determine when boosters should be given, noting the mRNA technology used in the Pfizer and Moderna vaccines has been around for years.
Arthur added that the mRNA technology will be able to be used for many vaccines and even disease treatments.
“You can speed the next product, and that can allow us to have many more innovations from the treatment perspective and the vaccine perspective,” she said. “It’s the same for monoclonal antibodies. And that will ripple through the industry for years to come.”
Cannon said he’s proud of the health care workers who are surrounded by contagious Covid patients putting them and their families at risk, but continue to step up every day for the greater good of the community.
Nonetheless, he said, he worries about the stress they endure, seeing so much loss and knowing it could be prevented.
Meanwhile, he said, although medical residents got the experience of learning how to work in the midst of a pandemic - something their predecessors never had - they are missing out on some hands-on training because hospitals are canceling elective procedures.
Kennedy said the employees who refused vaccination weren’t willing to listen to the science. And while she got lots of phone calls asking whether there were protests in the street about her mandate, it all went smoothly.
“There were a couple people grumbling in the plant,” she said, “but it amounted to much ado about nothing.”
All the speakers encouraged everyone to be vaccinated and wear masks.
“It will prevent you from giving the virus to someone else,” said Cannon, “or from them giving it to you.”
“We’re in this together,” said Arthur, “and we can get out of it together.”
Another hospital system mandates vaccines for workers see more
Another hospital system in the Lowcountry will soon mandate that workers get a COVID-19 vaccine as a condition of employment.
Roper St. Francis alerted its approximately 6,000 employees of the impending requirement on Aug. 24. The announcement comes a day after the federal Food and Drug Administration granted full approval to the Pfizer vaccine for people 16 and older and comes amid a new surge of COVID patients flooding hospitals and intensive care units across South Carolina.
“We are proceeding with this requirement because we care about you and our patients,” Roper St. Francis wrote in an email to employees. “This mandate is unanimously supported by the RSFH Board of Directors, senior leadership and our medical staff.”
Roper St. Francis staff who are not fully vaccinated must get their first dose by Oct. 1 and their second dose by Nov. 1. Employees who intend to file medical or religious exemptions to the mandate must do so by Sept. 17. Roper St. Francis spokesman Andy Lyons said the details of those exemption forms are still being finalized and he did not yet know if employees who developed natural immunity through a previous COVID-19 infection would qualify for a medical exemption.
Lyons said approximately 1,500 of the system’s 6,000 employees have not been vaccinated yet.
The Medical University of South Carolina and the Ralph H. Johnson VA Medical Center in Charleston already require employees to be vaccinated. In July, MUSC fired five employees who declined to be vaccinated. Vaccines for Trident Health employees remain optional, but encouraged.
In the letter to employees, Roper St. Francis leaders said more than 3,600 health care workers across the country died during the first year of the pandemic and explained that unvaccinated hospital and health care employees create more risks for patients.
According to the latest hospital census, across all four Roper St. Francis hospitals, all but 14 of the 107 COVID-19 inpatients are unvaccinated. None of the vaccinated patients who are hospitalized are on ventilators.
Lou Kennedy authors a perspective every South Carolina resident should read see more
Nephron Pharmaceuticals Corp. manufactures lifesaving medications that help people breathe. In the midst of a pandemic, it is more critical than ever that our team stays healthy, so we can keep patients healthy.
This was one reason we stayed motivated over the past year to step up for our community, state and nation to aid the response to COVID-19. When the opportunity arose for Nephron to partner with Dominion Energy South Carolina and launch a COVID-19 vaccination drive-thru, we embraced it — just as many of our employees, myself included, jumped at the chance to be vaccinated.
It was the least we could do to help keep South Carolina’s recovery on track. After all, we have been proud of the way our state, guided by Gov. Henry McMaster, has led. We struck the right balance between public health and economic prosperity. We never closed down, and we avoided many of the problems neighboring states have battled.
However, I would be remiss if I failed to mention the lag our state — and, frankly, our company — has seen in citizens being vaccinated. The initial enthusiasm for getting vaccinated has given way to hesitancy. I want to change that. I hope my colleagues around the business community will join me in the effort.
Why is it important to me for the people of South Carolina, the employees of our company and workers everywhere to get vaccinated?
After a year of masks and mandates, viruses and virtual meetings, I am tired of having the economy impacted, and recreation curtailed, by concerns that interacting with people could lead to long-term health challenges, such as those associated with COVID-19. I agree with our governor: We do not need new restrictions in South Carolina. It is time to return to normal — for good.
I also believe in science. As the CEO of one of the fastest-growing pharmaceuticals manufacturers in the country, I work with dozens of brilliant scientists. We know there are real concerns about contracting COVID-19 and the new, dangerous strains of the virus cropping up around the world.
If we truly want to return to normal, and do so in a permanent way, then there is no alternative to getting vaccinated. Luckily, in South Carolina, there are countless places where vaccines are available. Come to the Nephron drive-thru vaccination location (in West Columbia) and get your shot. There is no charge. Or contact the state Department of Health and Environmental Control about where to get vaccinated. Again, there is no charge.
Do you own a business? Give your employees incentives to get the shot. We did. Employees who received the vaccine by a certain date at Nephron were entered into a drawing to receive free paid time off. This was a win-win — for workers, it was a chance to earn a meaningful prize, and for the company, it meant a safer and healthier work environment.
Nephron employees who still have not been vaccinated are required to wear masks. Like other critical health care and manufacturing facilities, Nephron is a place too many people depend on for us to risk a widespread outbreak of any virus. What we hope is that we can encourage enough of our employees to get vaccinated that we do not have to consider additional mandates or more serious measures in response to unvaccinated employees.
Vaccinations remain one of the surest ways each of us can do the right thing — by our friends, families, state and nation — during these unprecedented days. If you have not been vaccinated, I hope you will join me and get the shot. Each of us can contribute to the health and safety of our companies and our country. Doing so may mean the difference between keeping the place where you work open and seeing it closed — not to mention the difference between life and death.
Lou Kennedy is CEO of Nephron Pharmaceuticals Corporation and a Lexington resident.
Life sciences booming in Spartanburg, Upstate see more
Spartanburg County – and the entire Upstate – are welcoming a growing interest and investments from life sciences companies. The Upstate has a long-established history and infrastructure that have supported life sciences companies with raw materials, production and packaging operations, and distribution.
Now, new research and innovation businesses are further supporting industry growth and fueling an ecosystem ripe for start-ups.
More than 670 life sciences firms of all sizes call the Upstate home, with 13 companies announcing new locations in the area in the last few years.
The newest of those companies in Spartanburg is Epica International, the leader in advanced, ultra-high-resolution mobile medical imaging and robotic applications for human and animal health, and industrial enterprises.
The company announced its headquarters and operations in Spartanburg, covering its subsidiary companies Epica Human Health, Epica Animal Health and Roboticom. Epica established corporate, imaging and robotic system demos at its facility, currently located inside the Spark Center SC on the Tyger River Campus of Spartanburg Community College.
“Epica’s investment in Spartanburg goes hand-in-hand with a diversified economic development strategy we’ve put in place countywide, targeting specifically investments from bioscience and life sciences industries,” said OneSpartanburg, Inc. Chief Economic Development Officer Katherine O’Neill. “These types of advanced, heavy-technology industries coming to our county gives us a considerable strategic advantage for future development and job growth.”
Another life sciences company – Pall Corporation – announced its intent to invest in Spartanburg County earlier in 2021. Pall announced its Spartanburg County operations would create 425 new jobs and $30.2 million in investment.
Pall serves the needs of customers across the broad spectrum of life sciences and industry and works with clients around the world to advance health, safety and environmentally responsible technologies. The company’s Spartanburg facility supports the rapid development of vaccines and therapeutics, including COVID-19 vaccines.
"Spartanburg County provides Pall with the diverse workforce we need to manufacture life-saving therapeutics and vaccines. We look forward to building our presence in this county,” said Pall Life Sciences President Joseph Repp at the time of the company’s announcement.
Statewide, South Carolina has a significant presence in the medical device sector. And the manufacturing supply chain is robust when it comes to life sciences, mirroring the strength of the area’s overall manufacturing prowess.
From 2015-2019, medical devices and equipment companies added 35% more jobs and accounted for 11.5% of the new companies coming to the Upstate. And on top of that, more than 700 clinical trials are being undertaken across the Upstate at any given time in the fields of oncology, companion diagnostics, genetics and more.
The Upstate in particular has a network of acclaimed hospitals, technical training schools and more than 26 colleges and universities actively working with industry leaders and educators on all levels to ensure access a highly-skilled workforce for decades to come.
“Spartanburg’s historic advantages when it comes to infrastructure, distribution capabilities and even the county’s location, make it a favorable home for continued investments from biosciences and life science industries,” said O’Neill. “That positions us well for the future as these industries continue to bring higher-wage, knowledge-based jobs to Spartanburg.”